The effect of probiotic supplementation on sexual performance

Phase 3

Recruiting

Conditions: Sexual dysfunction.
F52
sexual dys

Registration Number: IRCT20120718010324N83

Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Female

Target Recruitment: 64

Inclusion Criteria

Married women aged 40 to 60 years with menstrual irregularity or menopause
Having sex at least twice a month
Her husband being monogamous
Women's sexual function index questionnaire score FSFI<28 in the initial assessment
? A minimum of 12 months and a maximum of 10 years have passed since menopause in menopausal people
? Occurrence of natural menopause in menopausal people and not following hysterectomy surgery or GnRH receptor agonist drugs

Exclusion Criteria

Allergy to any of the products containing probiotics
Use of any immunosuppressive drugs
Use of drugs that affect sexual performance by the person himself or his wife
History of hormonal treatment due to sexual dysfunction during the last two weeks
Bleeding or spotting after intercourse, vaginal infection
Women who use sexual performance enhancing drugs
Addiction of spouses to drugs or alcohol
The presence of chronic diseases such as heart disease, diabetes, lupus, mental disorders, etc.
History of complete hysterectomy
Anatomical deformity of the external genitalia
History of pelvic chemotherapy and radiotherapy
Severe emotional stress during the 3 months before the start of the study
Use of phytoestrogens and other herbal medicines
Urinary incontinence

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Average sexual performance score. Timepoint: At the beginning of the study and eight weeks after the start of the intervention. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.

Secondary Outcome Measures

Name	Time	Method
Average quality of life score. Timepoint: At the beginning of the study and eight weeks after the start of the study. Method of measurement: Menopause-Specific Quality of Life questionnaire.